The company takes stock of the work in the third quarter and puts forward the work requirements for the fourth quarter.
Release time:
2020-08-14
Company Counts Work in the Third Quarter and Proposes Work Requirements for the Fourth Quarter
News 10# July 22 and 23 , the Company successively held work analysis meetings for the pharmaceutical sector, directly affiliated enterprises and cement sector to summarize and count the work gains and losses in the third quarter and put forward requirements for the work in the fourth quarter.
In the first three quarters of this year, the company's production and operation conditions were generally good, and the benefits of all subordinate enterprises increased. In the third quarter business analysis meeting, the person in charge of each enterprise reported the work of the first three quarters, focusing on the analysis of existing problems, and put forward solutions and improvement plans. Chairman Jiang Xiaomeng, General Manager Yu Jianhong and other group company leaders combined the economic and technical data of each enterprise in the first three quarters to comment on the work of each business sector one by one, point out the highlights of the work, analyze the problems and deficiencies, and put forward guidance and work requirements.
Peak Pharmaceutical Industry: Adjust Thinking, Accurate Positioning, Achieve Breakthrough
Since this year, pharmaceutical companies have improved compared with previous years in terms of production management, technological research, marketing expansion, etc. The sales volume of independent products and the operating profit of the parent company have increased significantly. With the continuous advancement of the medical system reform, new changes and new situations have appeared in the pharmaceutical industry and the market, and the pressure on the production and operation of enterprises has continued to increase, which has also exposed some shortcomings of the enterprise itself. Therefore, the meeting requires that pharmaceutical companies should adjust their management ideas in time according to the changes of the current industry situation, accurately position the management of subordinate enterprises, and strive to improve the R & D ability, bid winning ability and brand influence, so as to realize the overall improvement and development breakthrough of enterprise management. The meeting of
requires that pharmaceutical companies should fully understand the industry development trend brought about by the reform of the medical system, and make corresponding changes in team management ability, thinking mode and management means according to the current situation of enterprises, so as to correctly cope with the new industry environment and market environment. Pharmaceutical business should establish a replicable and standardized management mechanism as soon as possible to speed up the distribution of retail pharmacies, timely consideration should be given to the coordinated development and management integration of wholesale allocation and retail. The management orientation of new enterprises such as North Carolina and Zhongwang should be clear, and the management objectives should be clear about the schedule, time node and responsibility assessment. While effectively improving the management level, attention should also be paid to the indoctrination and cultivation of peak enterprise culture. Internationalized projects should design a good development path, follow up follow-up products and follow-up projects, find breakthroughs and go out boldly; pay more attention to product research and development and consistency evaluation, increase internal assessment and incentives, strengthen responsibilities, and improve employee enthusiasm; strengthen basic marketing work, strengthen assessment and incentives, and achieve marketing breakthroughs; do a good job in safety, environmental protection and quality management for enterprises Production and operation provide reliable guarantee.
Cement Plate: Strengthen the sense of responsibility, improve the operation efficiency, and establish the regional advantage
In the first three quarters of this year, the overall benefits of the two cement enterprises in the peak have improved year on year, the overall production indicators have improved, and the safety, environmental protection, technological transformation and other work have achieved remarkable results. The meeting called on the two enterprises to strengthen the sense of responsibility of managers at all levels, boost their work style and manage "sinking", find and solve problems on the front line, strive for excellence in every detail of work, and improve the overall operation level of the enterprises. We will earnestly and comprehensively strengthen the management of raw combustion materials, include self-provided mining in the annual plan, and strengthen the inspection of purchased materials to ensure reasonable use and controllable indicators, so as to provide guarantee for the stability of product quality; further strengthen equipment management, improve the quality of inspection and equipment maintenance, and ensure the stable operation of equipment; formulate norms and standards for "green enterprises" and "clean factories", and conscientiously do a good job in environmental protection and safety management; pay close attention to the changes in the situation of the cement industry, fully grasp the future market, and carry out work with the concept of "regional cost leadership". Establish the competitive advantage and voice of the regional market.
International Trade Company: Strengthen management, expand business, and control costs
This year is the best year since the establishment of international trade companies. The meeting requires international trade companies to combine the actual situation of the company., Pay close attention to the construction of a standardized and standardized management system, improve the level of management standardization, and improve the quality of service, provide guarantee for further introduction of new business and realization of management improvement; Increase the introduction and expansion of new business, enrich warehousing business and increase logistics throughput; Establish a cost control system, tap potential from every detail, eliminate management loopholes, reduce operating costs, and strive to establish cost advantages; Do a good job in the planning of the park and the management of projects under construction, so that the new warehouse can be put into use as soon as possible.
Cable Company: Enhance Ability, Expand Market and Extend Enterprise Vitality
Conference fully affirmed the achievements of cable companies in cost control, market expansion and mobilization of employees' passion for work this year. In view of the current cable market situation, the meeting requires cable companies to continue to improve their technical level and process capabilities, do a good job in production and quality management; continue to expand the market, consolidate and extend the market field, extend the vitality of enterprises, improve profitability, and strive for greater benefits.
Peak Health: Strengthen Innovation, Strengthen Quality and Cost Management, Seek Breakthrough
Meeting Requires Peak Health Company to Further Clarify Enterprise Development Positioning, Study and Improve Marketing Mode, and Strive for Market Breakthrough; Introduce and train talents without sticking to one pattern, strengthen team building, and realize business expansion; Do a good job in raw material procurement, acceptance, storage, quality control and yield improvement in production, pay attention to cost management from every node, strengthen scientific and technological innovation, constantly enrich varieties around product positioning, and clarify the path and method to achieve management objectives, so as to lay a good foundation for the further development of enterprises. At the
meeting, all enterprises were also required to seriously understand the company's requirements, do a good job in the preparation of the development plan for the next three years, and cooperate with the company in the formulation of the new five-year development strategy. (this newspaper reporter)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page